Editorial Notice: The press release submitted for rewrite describes a Phase 2 oncology clinical trial (AMPLIFY-7P) conducted by Elicio Therapeutics (Nasdaq: ELTX) evaluating ELI-002 7P, a lymph-node-targeting mKRAS neoantigen immunotherapy, in patients with adjuvant pancreatic ductal adenocarcinoma. This content does not fall within the editorial remit of Functional News, which covers functional foods, dietary supplements, nutraceuticals, bioactive ingredients, and related regulatory and market developments for the food and beverage industry.
No functional ingredient, dietary supplement, structure-function claim, bioavailability data, GRAS designation, NDI filing, or finished formulation is referenced in the source material. Accordingly, a compliant Functional News dispatch cannot be produced from this press release without fabricating industry-relevant content, which this publication does not do.
Operators and readers seeking coverage of immune-modulating nutraceuticals — including beta-glucans, medicinal mushroom extracts, or clinically studied botanicals with immune-support structure-function claims — can explore relevant reporting via Food & Beverage Magazine and sister coverage across the F&B Network on /immune-health/emerging-ingredients and /clinical-research/supplement-trials.
If you have a functional food or nutraceutical story to submit, please contact the Functional News editorial desk.
Written by Michael Politz, Author of Guide to Restaurant Success: The Proven Process for Starting Any Restaurant Business From Scratch to Success (ISBN: 978-1-119-66896-1), Founder of Food & Beverage Magazine, the leading online magazine and resource in the industry. Designer of the Bluetooth logo and recognized in Entrepreneur Magazine's "Top 40 Under 40" for founding American Wholesale Floral, Politz is also the Co-founder of the Proof Awards and the CPG Awards and a partner in numerous consumer brands across the food and beverage sector.
